道彤投资

Over 50,000 Cases in a Single Day! Inside the Speed of Landing AI's Cervical Cancer Screening | Dalton Venture Family

Landing Med aims to automate, digitize, and scale cytological pathology diagnosis through AI-powered, cloud-based diagnostic technology — enabling intelligent, networked, and standardized early detection of high-incidence tumors.

Into the Dalton Family | Melody Medical: Opening a New Chapter in RDN Therapy, Netrod® — China's Original Innovation — Takes the Global Stage

Hypertension is one of the most common diseases worldwide, severely impacting patients' health and quality of life. Nearly **1.28 billion adults** globally suffer from hypertension, yet awareness of the condition stands at just **54%**. Over 700 million hypertensive patients remain untreated, and only **21%** of adults with hypertension have their blood pressure under control. Prevention and treatment of hypertension carries profound significance for patients, families, and society at large.

Dalton Venture's Sun Qi: Prioritize Hard-Tech Sectors That Serve National Needs, Prioritize Solving Supply Chain Security Issues | Dalton Insights

At the "2023 China Investment Annual Conference" summit, Sun Qi shared his perspectives and experience with fellow guests on the topic of *How Much Longer Is the Window for Domestic Substitution in Medical Devices?*

A Visit to a Dalton Venture Family Company | Heyuan Bio's Lulu Lyu: China's Homegrown CAR-T Therapy Is About to Become Reality, Bringing New Hope for Relapsed or Refractory Acute Lymphoblastic Leukemia Patients

"After nearly five years, He Yuan Bio's first core product, inaticabtagene autoleucel injection, has treated more than 100 Chinese patients in clinical studies for acute lymphoblastic leukemia — representing the largest accumulated dataset to date on CD19 CAR-T clinical safety and efficacy in a Chinese patient population."

Dalton Venture's Lin Zhencheng: Technology Commercialization Gains Momentum, Capital Should Do More to Help Projects Cross the Commercialization Chasm | Dalton Insights

Dalton Venture's Lin Zhencheng was invited to participate in the Future Healthcare 100 · Trend Summit to discuss the next disruptive innovation track in life sciences.

Spring Tide Surges, A Thousand Sails Compete — Dalton Venture Annual CEO Summit | Tong Learning Society

Gather friends, gather energy, gather spirit

Survival of the Fittest | Dalton Venture 2022 Annual Partners Meeting (Part 2)

Deep post-investment management has always been one of Dalton Venture's distinguishing strengths. How does that post-investment support ultimately translate into portfolio company growth?

Survival of the Fittest | Dalton Venture 2022 Annual Partners Meeting (Part One)

Xiangxin — it's both "sunflower" + "heart," and the idea that following your inner passion lets you always grow toward the sun.

Ideas Flowing Like a "Spring" — A Dalton Venture Maritime Silk Road Team Outing in Quanzhou

The Essential GP Skillset Today: Reading Policy, Reading the Macro Trend, and Getting the Timing Right | Dalton Insight

China's past economic growth was bought with high-intensity input of production factors. The only way to break through going forward is to use technology to transform production relations and shift toward high-quality development.